about
β1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastomaΔNp63 isoform-mediated β-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma.Intelligent Nanoparticles for Advanced Drug Delivery in Cancer TreatmentMicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1.Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1.Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47Leukocyte arrest: Biomechanics and molecular mechanisms of β2 integrin activationSnake venom causes apoptosis by increasing the reactive oxygen species in colorectal and breast cancer cell lines.Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.Modifying the tumor microenvironment using nanoparticle therapeuticsAnti-angiogenic activity of salvicine.Mutational load and mutational patterns in relation to age in head and neck cancer.MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1Methylseleninic Acid Provided at Nutritional Selenium Levels Inhibits Angiogenesis by Down-regulating Integrin β3 SignalingMyeloid cells in tumor inflammation.Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma.Resistance to Anti-Angiogenic Therapy in Cancer-Alterations to Anti-VEGF Pathway.
P2860
Q24564890-BFC9137B-77B8-41E4-A240-434829AD2A0CQ33688451-B421F529-6A76-4EDA-A0AE-C97B24AB4BC3Q35000572-7F630086-C420-4D55-8455-CC9EC2227909Q35258620-789929DB-056F-44DE-B084-D0120D9C75F4Q35713332-E8FBB01B-C088-4A9E-A628-2F3CF42C42B4Q36592509-C1366C16-1BC8-4585-9237-5CB72A76416AQ36685489-6A1FEAF2-D129-4702-B9F5-B3EA84930D9CQ36908674-48BB7FB6-8058-4789-8071-83A72DD344D5Q37365515-ED075624-F1EB-40E8-98F7-D91A158F50EBQ37373141-28628824-0806-4B8B-BC00-12BC65492BEAQ38796320-32AAEB9A-B5B3-4C98-B533-28E11C025853Q39141799-C2CD0AEF-95C4-4CF5-8295-D11F3AC0BA54Q40551355-11FE6597-B0B5-480F-9980-E85282384518Q41296584-2C242828-A42A-4DC5-84FF-755294A48604Q41534532-8DABDAC4-026F-4732-BE84-614156A18CA5Q42408323-2B12E935-11B8-45D4-B9A0-9990A45FBB8BQ43763382-853CA816-003F-40A3-834C-EBA170E9D16BQ47162440-BEC26FFB-EFDF-4451-B289-5EF849327AEAQ52579594-D6060601-5FDE-4936-8609-C3F9417E2B52
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Integrins in tumor angiogenesis and lymphangiogenesis.
@en
Integrins in tumor angiogenesis and lymphangiogenesis.
@nl
type
label
Integrins in tumor angiogenesis and lymphangiogenesis.
@en
Integrins in tumor angiogenesis and lymphangiogenesis.
@nl
prefLabel
Integrins in tumor angiogenesis and lymphangiogenesis.
@en
Integrins in tumor angiogenesis and lymphangiogenesis.
@nl
P2860
P1476
Integrins in tumor angiogenesis and lymphangiogenesis.
@en
P2093
Philippe Foubert
P2860
P304
P356
10.1007/978-1-61779-166-6_27
P407
P577
2012-01-01T00:00:00Z